Clinical Trial Update: Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck [EARLY_Phase 1]

View source ↗

Summary

This report documents the completion of a Phase 1 pilot trial evaluating the combination of raltegravir and cisplatin in head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Isentress (Raltegravir)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: COMPLETED